This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
More Standards PDF
CSA C22.2 NO. 211.1-M1984 (R2003)
$162.00 $325.00
CSA C22.2 NO. 227.2-93 (R1999)
$23.00 $47.00
CSA C301.1-1976 (R2003)
$29.00 $58.00
CSA ANSI Z21.40.4-1996 (R2022)/CGA 2.94-M96 (R2022)
$312.00 $624.00





